Global Glaucoma Therapeutics Market | Worldwide Research, Prominent Players, Emerging Trends, Investment Opportunities

0
108

Rising demand for novel therapeutics among aging population will enable growth in the global glaucoma therapeutics market. Recently Fortune Business Insights has published a report, titled “GLAUCOMA THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2020-2027.” According to the report, in 2019 the global glaucoma therapeutics market was worth US$ 6.59 Bn. However, the global market is anticipated to expand at a CAGR of 6.1% and reach US$ 11.05 Bn by the end of 2027. The report also classifies the global glaucoma therapeutics market on the basis of various segments.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/glaucoma-therapeutics-market-100312

According to the report glaucoma therapeutics market in North America was worth US$ 2405.9 Mn in 2018. The region is expected to dominate the global market during the forecast period 2020-2027. The growth predicted in North America is attribute to its constantly improving healthcare facilities and adoption of recent advances in glaucoma diagnosis, treatment, and medication. These factors also are expected to bode well for the global glaucoma therapeutics market. Meanwhile, the increasing number of glaucoma cases in nations such as China and India is projected to enable growth in Asia Pacific. Additionally, the region is anticipated to progress at a relatively high CAGR.

Allergan and Novartis AG, Together Leading the Global Market Since 2018

The global glaucoma therapeutics market is witnessing an influx of new players. Allergan and Novartis AG, are currently leading players in the global market. The companies are involved in manufacturing and marketing of prostaglandin analogues. Among, prostaglandin analogues Lumigan and Travatan are the two most preferred medications for the treatment of glaucoma. Quality production and marketing of these drugs have enabled the organizations establish a stronghold in the global market. Besides this, other companies operating in the market are Pfizer, Inc., Merck & Co., Inc., Bausch & Lomb Incorporated, Teva Pharmaceutical Industry, Aerie Pharmaceuticals, Pfizer, Inc., and Inotek Pharmaceuticals.

In the coming years, the global glaucoma therapeutics market during is forecast to exhibit a steady growth rate. The report finds that factors such as increasing number of glaucoma cases and technological advancements in diagnostic kits will enable the market gain momentum in the coming years. Additionally, recent innovations by market players for glaucoma’s treatment and increasing purchasing power are major factors expected to boost the global market.

However, high cost associated with glaucoma’s medication and treatment is a key factor that may hamper the growth rate in the market.

Top Player:

  • include Pfizer, Inc.,
  • Merck & Co., Inc.,
  • Bausch & Lomb Incorporated,
  • Teva Pharmaceutical Industry,
  • Aerie Pharmaceuticals,
  • Pfizer, Inc.,
  • Inotek Pharmaceuticals.

In December 2017, Aerie Pharmaceuticals Inc. introduced new eye drops called Rhopressa. The eye drop is specially designed for faster treatment of glaucoma. This may also positively impact the organization’s current position in the market and enable it gain higher share in the global glaucoma therapeutics market.

Quick Buy – Global Glaucoma Therapeutics Market:

https://www.fortunebusinessinsights.com/checkout-page/100312

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

Table of content:

  • Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Key Insights
  • Prevalence of Glaucoma by major countries
  • Recent industry developments such as partnerships, mergers & acquisitions
  • Pipeline analysis
  • Reimbursement scenario by key countries
  • Regulatory scenario for key countries

Toc Continue…..

Speak to Analyst at:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/glaucoma-therapeutics-market-100312

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs